Jeff Brown Investment Company (JBIC) is a publicly traded company which specializes in investing in high risk, high reward products.
Jeff Brown is a veteran of the investment business with a number of investments in various industries.JBIC is known for its extensive investment portfolio, which includes a number the high-tech start-ups, healthcare, renewable energy, and health care sectors.
These include:Bubble Fund (formerly BioEnergy)BioEnergy is a biotechnology company with operations in the U.S., U.K., and Australia.
BioEnergy employs nearly 400 people in the United States and Canada.
BioEnergy’s research and development has been focused on the development of biofuels.
Bioenergy is owned by a number companies in Europe and Asia.
The company was founded in 2008 by a team of entrepreneurs who had previously invested in the start-up of a new medical device company.
Bio Energy acquired a majority stake in the company in January 2017.
The acquisition of a controlling stake in a company that has significant assets and operations in other countries has created an opportunity for the company to accelerate its development and the growth of its business in those countries.
Bio Energy is an accredited investor in some countries.
Bubbleship Capital (formerly Enercare)Enercare is an American healthcare and wellness start-Up, founded in 2018.
It is the first start-UP in the world to have a $50 million Series A financing round.
EnerCare aims to provide an on-demand, personalized care experience for patients.
EterCare has also partnered with some of the most prominent healthcare and health technologies companies in the industry.
EnerCare has over $2 billion in annual revenues and is expanding rapidly.
Eber Health, a leading provider of health care and wellness technology, is a minority shareholder of Ener Care.
Eber Health’s goal is to be one of the leading providers of health and wellness solutions.
Energizer (formerly Gilead Sciences)Gilead has acquired a minority stake in Ener Health, and Ener has been working on an acquisition of Gileard’s U.N. Health Ventures (U.N.)
The deal will give Gileads’ U.P.A. $200 million investment in Energizer, a company which provides the technology and clinical expertise to manage and treat infectious diseases.
Gileads has also recently partnered with Gileader, a healthcare company with over $50 billion in assets, and it has invested in other companies including NuvaRing, Gileaders Health Ventures and Gileades, a U.G.P.-based pharmaceutical company.
GainShares (formerly Cephalon)Cephalons U.B.C. (formerly Genentech)Genentech is a global pharmaceutical company which has more than $10 billion in revenues.
Genentec has been growing rapidly in recent years, and its new strategic partnership with GainShares will allow it to increase its share of the market for healthcare and pharmaceuticals.
Genetech has been expanding into a number areas, including healthcare, biotechnology, biosciences, and medical devices.
Genecal has a minority shareholding in GainShares.
Gemma Partners (formerly Arian Foster)Arian Foster has been an entrepreneur and philanthropist since his college days.
In 2017, he began working as a board member of the Emory University Health Sciences Center, where he began a leadership and philanthropic initiative that includes investing in leading research universities, helping fund health systems and other health research, and advocating for the future of innovation.
Foster’s investments include the Foster Foundation, which provides research funding to philanthropic organizations that support the development and application of science-based treatments for the human condition.
In 2016, Foster launched his own health care investment fund, the Foster Health Fund, which was subsequently sold to an independent fund.
Facing a shrinking number of patients, Foster is also focused on developing innovative ways to care for the billions of patients who currently lack access to quality, affordable healthcare.
His VisionCare Foundation invests in healthcare startups, supports high-quality, low-cost access to affordable care, and is one of only a handful of public foundations with a direct investment in healthcare.
Ferrari has a number partners and investors that invest in the healthcare sector.
In 2018, Ferrari invested in Emory’s Emory Health Ventures, a venture capital fund.
Ferrari is a founding member of Emory Ventures, and has also invested in several startups in the health care industry.
Ferrari has also worked with Emory on a number other projects, including Emorys VisionCare and Emory VisionTech, and in 2018 launched the Emories VisionCare platform.
In March 2019, Ferrari and Emories partners joined forces to establish EmoryVision, an in-person health technology innovation hub, which seeks to provide high-impact, low cost access to high